No Picture
News

MediciNova Receives Notice of Intention to Grant for New Patent Covering MN-001 for the Treatment of Idiopathic Pulmonary Fibrosis in Europe

LA JOLLA, Calif., Jan. 27, 2020 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that it has rece… […]

No Picture
News

Opentrons Labworks and Swift Bioscience Launch "Plug-&-Play" NGS Library Preparation Automation Workstation

NEW YORK–(BUSINESS WIRE)–Opentrons Labworks, Inc. (“Opentrons”) and Swift Biosciences, Inc. (“Swift”) announce the launch of the most affordable fully-automated workstation for next-generation sequencing (NGS) library preparation ever put on the mark… […]

No Picture
News

Onvasertib Demonstrates Effectiveness as Pan-KRAS Inhibitor with Confirmed Tumor Regression and Clinical Benefit Achieved in KRAS-Mutated mCRC Patients

– All patients showed tumor regression by radiographic scan at 8 weeks and confirmation by further tumor shrinkage at 16 weeks; clinical benefit achieved in 100% (n=5) of patients- Tumor regression occurred across all major KRAS mutation types in CRC, … […]